Aldehyde Dehydrogenase 2 rs671 G/A and a/A Genotypes are Associated with the Risk of Acute Myocardial Infarction
Youqian Li,Wei Zhong,Zhidong Liu,Changjing Huang,Junyin Peng,Hanlin Li
DOI: https://doi.org/10.2147/ijgm.s475756
IF: 2.145
2024-08-20
International Journal of General Medicine
Abstract:Youqian Li, 1, 2 Wei Zhong, 1, 2 Zhidong Liu, 1, 2 Changjing Huang, 1, 2 Junyin Peng, 1, 2 Hanlin Li 1, 2 1 Center for Cardiovascular Diseases, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, Meizhou, People's Republic of China; 2 Guangdong Provincial Engineering and Technology Research Center for Molecular Diagnostics of Cardiovascular Diseases, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, Meizhou, People's Republic of China Correspondence: Youqian Li, Center for Cardiovascular Diseases, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, No. 63 Huangtang Road, Meijiang District, Meizhou, People's Republic of China, Email Background: Aldehyde dehydrogenase 2 (ALDH2) is a key catalytic enzyme involved in the aldehyde metabolism that plays an important role in the occurrence and development of acute myocardial infarction (AMI). However, the relationship of ALDH2 polymorphism and susceptibility to AMI may differ among different regions and populations, and it has not yet been reported in Hakka population. The purpose of the present study was to investigate it in this population. Methods: Four hundred and nineteen AMI patients and 636 individuals without AMI were included in the present study. The ALDH2 rs671 polymorphism was genotyped using polymerase chain reaction (PCR)-microarray. Differences in ALDH2 rs671 genotypes and alleles between patients and controls were compared, and the relationship between ALDH2 rs671 genotypes and AMI risk was analyzed. Results: Patients with AMI had a lower frequency of ALDH2 rs671 G/G genotype (43.2% vs 52.7%, p =0.003), and a higher G/A genotype (45.6% vs 38.5%, p =0.025) than controls. And AMI patients had a lower frequency of ALDH2 rs671 G allele (66.0% vs 71.9%), and a higher A allele (34.0% vs 28.1%) ( p =0.004) than controls. Logistic regression analysis showed that overweight (body mass index (BMI)≥ 24.0 kg/m 2 vs BMI 18.5– 23.9 kg/m 2 : odds ratio (OR) 2.046, 95% confidence interval (CI): 1.520– 2.754, p < 0.001), history of hypertension (yes vs no: OR 3.464, 95% CI: 2.515– 4.770, p < 0.001), ALDH2 rs671 G/A genotype (G/A vs G/G: OR 1.476, 95% CI: 1.102– 1.976, p =0.009), and A/A genotype (A/A vs G/G: OR 1.656, 95% CI: 1.027– 2.668, p =0.038) maybe the independent risk factors for AMI. Conclusion: Overweight (BMI≥ 24.0 kg/m 2 ), a history of hypertension, and ALDH2 rs671 G/A or A/A genotypes increased the risk of developing AMI in Hakka population. Keywords: aldehyde dehydrogenase 2, acute myocardial infarction, polymorphism, Hakka Coronary artery disease (CAD) is a heart disease caused by myocardial ischemia or necrosis due to stenosis, blockage and spasm of the coronary artery atherosclerosis. 1,2 Acute myocardial infarction (AMI) is a severe form of CAD, caused by the rupture of coronary atherosclerotic plaques, the acute occlusion of the coronary artery leading to interruption of blood flow, and the myocardial necrosis caused by severe and persistent ischemia and hypoxia. 3,4 AMI is an important disease burden worldwide, with a high fatality rate, 5,6 there are approximately 290 million cardiovascular patients and 2.5 million have AMI in China. 7,8 It is of great significance to identify individuals susceptible to AMI. The pathological basis of AMI is atherosclerosis. At present, atherosclerosis is regarded as a chronic inflammatory disease characterized by a sequence of immune responses, and inflammation plays an important role in the occurrence and development of atherosclerotic lesions. 9 The formation of atherosclerotic plaque is characterized by lipid accumulation, local vascular inflammation, proliferation of smooth muscle cells (SMCs), apoptosis, and fibrillation, which is mainly the activation of inflammatory cells and a series of chronic inflammatory reactions triggered by endothelial cell injury. 10 The anti-inflammatory treatment of AMI is also receiving more research and attention. 11 Some indicators that can reflect the systemic or local inflammation level have potential value in the diagnosis and prognosis assessment of AMI, such as neutrophil-to-lymphocyte ratio (NLR), 12 blood cell ratios associated with immune cells, 13 fibrinogen albumin ratio (FAR), 14 and C-reactive protein (CRP). 15 The body will produce a large number of reactive oxygen species (ROS) under stress, which intensifies the peroxidation of mito -Abstract Truncated-
medicine, general & internal